“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement
“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement
In the face of new challenges to the access to testing, prevention, care and treatment necessary to stop HIV transmissions, infections, illnesses and deaths at home and globally, the theme of this year’s World AIDS Day: Ending the HIV/AIDS Epidemic: Resilience and Impact must drive the efforts ahead.
Honoring careers in research, clinical care and education that have resulted in significant improvements or discoveries in HIV care, the HIV Medicine Association presented its 2020 Awards for Excellence to Adaora Adimora, M.D., FIDSA, and Gabriel Chamie, M.D., MPH, in October.
The four principles established by CDC’s Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine set a positive course for mitigating and containing the impacts of the pandemic.
Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate
With numbers of infections, illnesses, hospitalizations and deaths caused by COVID-19 at record highs as this holiday season begins, the risks posed by the spread of the coronavirus are more dangerous than at any time since its emergence last December.
We share and appreciate the urgency in expanding therapeutic options for COVID-19 as daily case counts and hospitalization rates reach record levels. For new therapeutics to be used widely and routinely outside of clinical trials, we urge that there be sufficient safety and efficacy data to be confident regarding their use.
The Senate Appropriations Committee’s funding proposal for FY2021 makes critical investments in the Ending the HIV Epidemic initiative and NIH but fails to include COVID-19 relief funding.
The Infectious Diseases Society of America and its HIV Medicine Association have reached out today to President-elect Joe Biden to congratulate him and to offer their memberships’ expertise as the new administration takes on the challenges of the COVID-19 pandemic and other infectious diseases threats.
New guidance published today by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates the 2013 guideline for providing comprehensive evidence-based primary care to people with HIV.
The Infectious Diseases Society of America, HIV Medicine Association, Pediatric Diseases Society and the Society of Healthcare Epidemiology of America have called on the Department of Homeland Security to exempt physicians working in the United States on J-1 visas from the agency’s proposed rule
"In September the Trump Administration released an “Executive Order on Combating Race and Sex Stereotyping,” which would allow federal agencies to terminate contracts intended to help promote study and understanding of diversity, equity and inclusion across government institutions."